Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

Eric Simpson, Abhijit Gadkari, Margitta Worm, Weily Soong, Andrew Blauvelt, Laurent Eckert, Richard Wu, Marius Ardeleanu, Neil M H Graham, Gianluca Pirozzi, E. Rand Sutherland, Vera Mastey

Research output: Contribution to journalArticle

87 Scopus citations

Fingerprint Dive into the research topics of 'Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)'. Together they form a unique fingerprint.

Medicine & Life Sciences